Read oxford vaccine latest news on The Economic Times. oxford vaccine updates, oxford vaccine developments, videos and more.

Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 ...

CAMBRIDGE, MA / ACCESS Newswire / September 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive preliminary immunogenicity data for the 2025-2026 formula of Spikevax®, which targets the LP ...

Pharma and biotech stocks rallied after the WHO flagged a hantavirus outbreak linked to a cruise ship, reviving investor bets ...

An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.

Abstract: Analysis of public response during health crises is crucial for policy-making. While clustering method is commonly used for analyzing public reactions, traditional topic modeling approaches ...

Stephen Ayers joins Nicole Benjamin on 'Portfolio Pulse' to discuss the precarious financial state of Moderna as it struggles to pivot away from its dwindling COVID-19 revenue toward a ...

CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License ...

Moderna forecasts lower-than-expected Q2 revenue Moderna aims for significant share of Europe's respiratory vaccine market with 2027 mCombriax launch International sales outpace US as partnerships ...

In the early weeks of the Covid pandemic, in those days when public spaces emptied and hospitals filled up, I used to see this magazine cover from 2017 being passed around social media. The story was ...